Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition

Cancer Research

Volumn 61, Issue 5, 2001, Pages 2320-2327

  Hartsough, Melanie T ^a   Clare, Susan E ^a,e   Mair, Michael ^a   Elkahloun, Abdel G ^d   Sgroi, Dennis ^b   Osborne, C Kent ^c   Clark, Gary ^c   Steeg, Patricia S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; NUCLEOSIDE DIPHOSPHATE KINASE A; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL MOVEMENT; CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MONOMERIC GTP-BINDING PROTEINS; NEOPLASM METASTASIS; NUCLEOSIDE-DIPHOSPHATE KINASE; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035266181     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Metastasis suppressed C8161 melanoma cells arrest in lung but fail to proliferate
2. Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases
3. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: Effects on tumor metastatic potential, colonization, and enzymatic activity
4. Nm23-transfected MDA-MB-435 human breast carcinoma cells form tumors with altered phospholipid metabolism and pH: A 31P nuclear magnetic resonance study in vivo and in vitro
5. Relationship of nm23 to proteolytic factors, proliferation, and motility in breast cancer tissues and cell lines
6. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells
7. Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line
8. Effects of cytokine mediated modulation of Nm23 expression on the invasion and metastatic behavior of B16F10 melanoma cells
9. Suppression of human melanoma metastasis following introduction of chromosome 6 is independent of NME1 (nm23)
10. Reduced metastatic potential and c-myc overexpression of colon adenocarcinoma cells (Colon 26 line) transfected with nm23-R2 rat nucleoside diphosphate kinase A isoform
11. Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastsis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture
12. Inhibition of cell motility after nm23 transfection of human and murine tumor cells
13. Site-directed mutagenesis of nm23-H1: Mutation of proline 96 or serine 120 abrogates its motility inhibitory activity upon transfection into human breast carcinoma cells
14. Reproductive state of rat mammary, gland stroma modulates human breast cancer cell migration and invasion
15. A novel function for Nm23: Overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest
16. Nm23/nucleoside diphosphate kinase in human cancers
17. The relationship between nm23, angiogenesis, and the metastatic proclivity of node-negative breast cancer
18. Individual characterisation of the metastatic capacity of human breast carcinoma
19. NME1 protein expression and loss of heterozygosity mutations in primary human breast tumors
20. X-chromosomal inactivation and cell memory
21. Genomic imprinting: Implications for human disease
22. DNA methylation and cancer
23. Alterations in DNA methylation
24. Reduced Nm23/Awd protein in tumor metastasis and aberrant Drosophila development
25. In vivo gene expression profile analysis of human breast cancer progression
26. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice
27. LCC15-MB: A vimentin-positive human breast cancer cell line from a femoral bone metastasis
28. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines
29. Epigenetic gene silencing in cancer
30. Inhibition of colonization and cell-matrix adhesion after nm23-H1 transfection of human prostrate carcinoma cells
31. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors
32. Tumor-specific distribution of BRCA1 promoter region methylation supports a pathogeneic role in breast and ovarian cancer
33. Methylation and silencing of the retinoic acid receptor-B2 gene in breast cancer
34. High frequency of hypermethylation at the 14-3-3-e locus leads to gene silencing in breast cancer
35. Hypermethylation of the Wilms' tumor suppressor gene CpG island in human breast carcinomas
36. Inactivation of p16 in human mammary epithelial cells by CpG island methylation
37. INK4a gene expression and methylation in primary breast cancer: Overexpression of p16(INK4a) messenger RNA is a marker of poor prognosis
38. Transcriptional regulation of urokinase (uPA) gene expression in breast cancer cells: Role of DNA methylation
39. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression
40. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas
41. Epigenetic silencing of maspin gene expression in human breast cancers
42. Number of CpG islands and genes in human and mouse
43. Aberrant CpG-island methylation has non-random and tumor-type-specific patterns
44. Suppression of intestinal neoplasia by DNA hypomethylation
45. Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide
46. Inhibition of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth of human tumor cell lines
47. DNA methylation of retinoic acid receptor b in breast cancer and possible therapeutic role of 5-aza-2′-deoxycytidine
48. Down-regulation of human DNA-(cytosine-5) methyltransferase induced cell cycle regulators p16ink4a and p21WAF/Cip1 by distinct mechanisms
49. De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells
50. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
51. Effects of all-trans retinoic acid and epidermal growth factor on the expression of nm23-H1 in human hepatocarcinoma cells
52. Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): Characterization of connective tissue growth factor as a member of the IGFBP superfamily
53. Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7
54. Identification of a novel M phase phosphoproteins by expression cloning
55. PECAM-1 (CD31) functions as a reservoir for and a modulator of tyrosine-phosphorylated β-catenin
56. Characterization of the human platelet endothelial cell adhesion molecule-1 promoter: Identification of a GATA-2 binding element required for optimal transcriptional activity
57. Examination of POU homeobox gene expression in human breast cancer cells
58. An endothelial growth factor involved in rat renal development
59. Isolation of transformation suppressor genes by cDNA subtraction: Lumican suppresses transformation induced by v-src and v-K-ras
60. Expression of lumican in human breast carcinoma
61. Independent modulation of collagen fibrillogenesis by decorin and lumican
62. Methylation-mediated regulation of the glutathione S-transferase P1 gene in human breast cancer cells
63. Epigenetic mechanisms for progression of prostate cancer
64. Cloning and characterization of the Yarrowia Lipolytica squalene synthtase (SQS1) gene and functional complementation of the Saccharomyces cerevisiae erg9 mutation
65. Specific interaction of eukaryotic translation initiation factor 5 (eIF5) with the β-subunit of eIF2
66. p12 (DOC-1), a growth suppressor, associates with DNA polymerase α/primase
67. Molecular cloning, characterization, and genetic mapping of the cDNA coding for a novel secretory protein of mouse - Demonstration of alternative splicing in skin and cartilage
68. Eukaryotic translation elongation-factor 1-γ contains a glutathione transferase domain - Study of a diverse, ancient protein superfamily using motif search and structural modeling
69. Phosphorylation and protein-synthesis during oocytes meiosis
70. CpG islands in veterbrate genomes